Back
Kiniksa Pharmaceuticals International PLC Stock Predictions
Sponsored
KNSA
Sponsored
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Sell
41
KNSA
Kiniksa Pharmaceuticals International PLC
Last Price:
21.38
Seasonality Move:
39.39%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.Kiniksa Pharmaceuticals International PLC Stock Forecast
- Over the next 52 weeks, Kiniksa Pharmaceuticals International PLC has on average historically risen by 17.4% based on the past 6 years of stock performance.
- Kiniksa Pharmaceuticals International PLC has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Kiniksa Pharmaceuticals International PLC Stock Undervalued?
The current Kiniksa Pharmaceuticals International PLC [KNSA] share price is $21.21. The Score for KNSA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal. - KNSA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Kiniksa Pharmaceuticals International PLC Stock Go Up Next Year?
- Over the next 52 weeks, Kiniksa Pharmaceuticals International PLC has on average historically risen by 17.4% based on the past 6 years of stock performance.
Kiniksa Pharmaceuticals International PLC Stock Rating
Sell
41
Kiniksa Pharmaceuticals International PLC (KNSA)
is a Sell
Is Kiniksa Pharmaceuticals International PLC overpriced?
- Kiniksa Pharmaceuticals International PLC has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Kiniksa Pharmaceuticals International PLC Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Bermuda
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kiniksa.com
52-Week Data
52-Week High:
28.15
52-Week Low:
15.51
Prediction Charts
Market Cap:
1.53B
Price in USD:
21.21
Volume:
245.58K
Beta:
0.06
Technical Analysis
SMA50:
24.39
SMA100:
24.30
SMA200:
21.77
52-Wk Change:
33.9%
Stock Predictions
-
Is Kiniksa Pharmaceuticals International PLC stock public?
Yes, Kiniksa Pharmaceuticals International PLC is a publicly traded company. -
What is the Kiniksa Pharmaceuticals International PLC stock quote today?
The Kiniksa Pharmaceuticals International PLC stock price is 21.21 USD today. -
How to buy Kiniksa Pharmaceuticals International PLC stock online?
You can buy Kiniksa Pharmaceuticals International PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-1 | 22.83 | 22.48 | 23.37 | 22.26 |
Nov-4 | 22.26 | 21.48 | 22.26 | 21.44 |
Nov-5 | 20.66 | 22.03 | 22.14 | 20.66 |
Nov-6 | 22.90 | 23.02 | 23.17 | 22.17 |
Nov-7 | 23.08 | 23.01 | 23.42 | 22.68 |
Nov-8 | 23.01 | 22.88 | 23.37 | 22.62 |
Nov-11 | 22.86 | 23.04 | 23.52 | 22.86 |
Nov-12 | 22.91 | 22.99 | 23.33 | 22.66 |
Nov-13 | 23.18 | 22.62 | 23.34 | 22.56 |
Nov-14 | 22.46 | 21.81 | 22.57 | 21.71 |
Nov-15 | 21.90 | 21.29 | 21.96 | 21.13 |
Nov-18 | 21.02 | 21.50 | 21.52 | 20.58 |
Nov-19 | 21.38 | 20.82 | 21.50 | 20.62 |
Nov-20 | 20.73 | 21.21 | 21.55 | 20.41 |
Kiniksa Pharmaceuticals International PLC Earnings
Kiniksa Pharmaceuticals International PLC Earnings Report: Per Share Kiniksa Pharmaceuticals International PLC Earnings Q1 Q2 Q3 and Q4 last year and next year.
Kiniksa Pharmaceuticals International PLC Forecast Revenue Growth
Kiniksa Pharmaceuticals International PLC Stock Analysis: Historical quarterly revenues per share for Kiniksa Pharmaceuticals International PLC and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and an increase next year of $0.89 per share.
* Kiniksa Pharmaceuticals International PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.